Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study
2007

Fenofibrate Treatment Reduces Liver Damage in Rats with Jaundice

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): Cindoruk Mehmet, Kerem Mustafa, Karakan Tarkan, Salman Bulent, Akin Okan, Alper Murat, Erdem Ozlem, Ünal Selahattin

Primary Institution: Gazi University Faculty of Medicine, Ankara, Turkey

Hypothesis

Does short-term administration of fenofibrate improve liver damage and inflammation in rats with obstructive jaundice?

Conclusion

Fenofibrate treatment significantly reduces liver damage and inflammation in rats with obstructive jaundice.

Supporting Evidence

  • Fenofibrate significantly reduced serum total bilirubin, AST, ALT, ALP, and GGT levels.
  • Hepatic portal inflammation and necrosis were significantly reduced with fenofibrate treatment.
  • Fenofibrate treatment increased the number of bile ducts in the liver.

Takeaway

Giving fenofibrate to sick rats helps their livers feel better and reduces damage.

Methodology

Forty male Wistar rats were divided into four groups: sham operated, bile duct ligation, bile duct ligation with vehicle, and bile duct ligation with fenofibrate, and evaluated after 7 days.

Limitations

The study was limited to a short treatment duration and animal model, which may not fully represent human conditions.

Participant Demographics

Forty male Wistar rats weighing 230–270 g.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1471-230X-7-44

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication